Two companies see record quarterly sales and five more updates from spine devicemakers in the last week:
The Latest
Royal Biologics received FDA approval for its MAXX-BMC bone marrow aspirate concentration system.
New York City-based Hospital for Special Surgery is shifting its focus from anterior cruciate ligament reconstruction to restoration by using the Bear implant.
Although further research is needed to determine the safety and efficacy of regenerative procedures in the spine, the potential of many of these therapies — such as stem cells, platelet-rich plasma and bone marrow aspirate — is considerable.
Louis Shapiro, president and CEO of New York City-based Hospital for Special Surgery, outlined the five focuses that can help make an organization great for the "Becker's Healthcare Spine and Orthopedic Podcast" May 25.
Coastal Orthopedics opened two new medical centers in Florida, in West Bradenton and East Manatee.
Here are seven spine surgeons who moved to new practices or added to their titles in May:
In hip replacement surgery, the sex of surgeon conducting the procedure made no real difference on the instance of negative outcomes, reported a study published in The Journal of Bone & Joint Surgery.
SI-Bone's iFuse Bedrock Granite implant system for sacroiliac fusion and sacropelvic fixation received FDA clearance.
Spine and orthopedic experts and leaders spoke with Becker's Spine Review on key topics in May from competition with large physician groups to threats in orthopedics.